Author

B. Lucic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:microscopy & imaging analysis· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

M. Lusic· 4 shared V. Laketa· 3 shared A. Savarino· 2 shared B. Müller· 2 shared C. J. Neufeldt· 2 shared H.-G. Kräusslich· 2 shared I. L. Shytaj· 2 shared M. Cortese· 2 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

M. Lusic

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication

I. L. Shytaj, M. Fares, B. Lucic, L. Gallucci, M. M. Tolba, L. Zimmermann, A. T. Ayoub, M. Cortese, C. J. Neufeldt, V. Laketa, P. Chlanda, O. T. Fackler, S. Boulant, R. Bartenschlager, M. Stanifer, , M. Lusic

This study shows that cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication in cell lines and organoids, reducing viral replication to levels comparable to uninfected cells.

bioRxiv · Mar 9, 2021Microbiology

Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera

C. Pape, R. Remme, A. Wolny, S. Olberg, S. Wolf, L. Cerrone, M. Cortese, S. Klaus, B. Lucic, S. Ullrich, M. Anders-Össwein, S. Wolf, C. Berati, C. J. Neufeldt, M. Ganter, , V. Laketa

The paper develops a semi-quantitative microscopy-based assay to detect SARS-CoV-2 specific antibodies in human sera, providing a sensitive and specific method for serological analysis.

BioEssays · Dec 30, 2020Peer-reviewedMicrobiology

Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress

I. L. Shytaj, F. A. Procopio, M. Tarek, I. Carlon-Andres, H.-Y. Tang, A. R. Goldman, M. Munshi, M. Forcato, K. Leskov, F. Ye, B. Lucic, N. Cruz, A. Singh, S. Bicciato, S. Padilla-Parra, , A. Savarino

The paper shows that glycolysis downregulation is a hallmark of HIV-1 latency and that targeting antioxidant pathways can reactivate latent HIV-1.

bioRxiv · Dec 30, 2020Immunology

HIV-1 uncoating by release of viral cDNA from capsid-like structures in the nucleus of infected cells.

T. G. Müller, V. Zila, K. Peters, S. Schifferdecker, M. Stanic, B. Lucic, V. Laketa, M. Lusic, B. Müller, H.-G. Kräusslich

The paper visualizes HIV-1 cDNA in nuclei using CLEM and shows that uncoating occurs via physical disruption of capsid-like structures, not cooperative disassembly.

bioRxiv · Nov 13, 2020Microbiology